Methylene blue, a vibrant synthetic dye first synthesized in 1876, has surged from hospital IVs to the forefront of alternative health and biohacking communities. Once primarily used for treating malaria, methemoglobinemia, and staining surgical sites, this coal tar-derived compound is now celebrated for its potential to boost mitochondrial function, enhance cognitive clarity, and combat chronic fatigue. Social media platforms like TikTok showcase users with blue-stained tongues, touting its energizing effects, while functional medicine practitioners integrate it into protocols for conditions like long COVID, Lyme disease, and cognitive decline. However, as its popularity grows, so do concerns about its safety and long-term impacts. Is methylene blue a cellular savior or a risky experiment? This post combines insights from two perspectives—a skeptical critique from GreenMedInfo and a cautious clinical take from Dr. Cassie Smith, MD—to explore the science, the hype, and the hazards of methylene blue.
Read MoreThe debate over GRAS isn't just about science—it's about trust. In the U.S., where distrust in institutions runs high, the idea that companies can secretly add chemicals to food under a vague "safe" label feeds public unease. Europe's system, while not perfect, offers a counterpoint: a government-led process that, though slower, prioritizes transparency and accountability. Kennedy's push to rethink GRAS taps into this sentiment, promising a reckoning for a food industry that many Americans feel has betrayed them. Yet, the question remains whether his bold vision can navigate the political and economic realities of a nation hooked on cheap, processed goods.
Read More